CVS Selling EpiPen's Competitor Product at One Sixth of the Current Price

0 1338

In September of 2016 the medical community, and the United States congress, were appalled when healthcare company Mylan Inc. announced a 500% price increase (now currently at a cost of $608 dollars) for a two-pack of allergy attack saving EpiPens. The free market once again comes to the rescue as CVS has just announced it is selling a generic version of the drug at a sixth of the price.

Continue Reading

Recommended Reading

Those who nourish the hope that it will be possible to keep central government free of the corrupting tendencies of power and to staff it with a freedom-loving elite, overestimate the virtues of both the electorate and the elected, and underestimate the normative power of structural processes even over well-intended functionaries.

- Robert Nef